Andrew Huberman· PhD
patients are selected because they have PTSD they meet the clinical criteria for PTSD they do three 90-minute therapy sessions with two therapists talking about their PTSD symptoms talking about to the extent that they can the incident that or incidents the life events that led to that PTSD none of that is done under the influence of any drug okay so everyone in the experiment does that then the group divides into two where half are taking MDMA they take that three times during those three times they are also receiving therapy sessions with the same therapists that they were working with before they took MDMA the first session they're taking 80 milligrams of MDMA and then a 40 milligram booster about an hour and a half to two hours in the second session they are taking a higher dose of MDMA it's 120 milligrams and then if they elect to they can take a 60 milligram booster about an hour and a half to two hours into the session and then there's a third session where they take again 120 milligrams of MDMA and have the option to take a 60 milligram booster about an hour and a half to two hours into the session again anytime they're on MDMA they have therapists there that they're talking to about their trauma they are either spending time with their eyes closed lying down sometimes in an eye mask and thinking about the trauma thinking about their current state and experience also thinking about what happened before then they're exiting the eye mask or talking to the therapist therapist is taking notes asking questions remember they've established a strong Rapport supportive relationship with these therapists prior to taking MDMA in the therapy session and then they also undergo three 90-minute therapy sessions with the two therapists spaced one week apart after the final MDMA session